DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Chiang CL, So TH, Lam TC, Choi HCW.
Cost-effectiveness analysis of abiraterone acetate versus docetaxel in the management of metastatic castration-sensitive prostate cancer: Hong Kong's perspective.
Prostate Cancer Prostatic Dis 2020;
23 (01) 108-115
We do not assume any responsibility for the contents of the web pages of other providers.